Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P105: Inhibition of cytokine release from HT-29 cells and ulcerative colitis biopsies is potentiated by combination of selective kinase inhibitors, and such effects are mimicked by TOP1210, a narrow spectrum kinase inhibitor ECCO '16 Amsterdam
Year: 2016
Authors:

M. R. Foster*1, P. Biancheri2, S. Sirohi1, Y. Solanke1, M. C. Fyfe1, A. Rowley1, T. T. MacDonald2, E. Wood3, S. Webber1, C. A. Walshe1

1Topivert Pharma Ltd, London, United Kingdom, 2Barts and the London, School of Medicine and Dentistry, London, United Kingdom, 3Homerton University Hospital, Academic Department of Medical and Surgical Gastroenterology, London, United Kingdom

P106: Maintenance treatment with granulocyte/monocyte adsorption in patients with inflammatory bowel disease and an initial response to treatment: a Swedish long-term prospective registry studyECCO '16 Amsterdam
Year: 2016
Authors:

A. Lindberg1, 2, S. Lindgren3, M. Lördal4, S. Nilsson5, H. Svensson6, P. Karlen*1

1Department of Clinical Science, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden, Stockholm, Sweden, 2Karolinska Institutet, Danderyds hospital, Department of Clinical Science, Stockholm, Sweden, 3Department of Gastroenterology, University Hospital Skane, Sweden, Malmö, Sweden, 4Department of Medicine, Division of Gastroenterology and Hepathology at Karolinska Institutet, Huddinge, Sweden, Stockholm, Sweden, 5Department of Medicine, Kristianstad Hospital, Kristianstad, Sweden,, Kristianstad, Sweden, 6Departments of Internal Medicine, Vrinnevi Hospital, Norrköping, Sweden, Norrköping, Sweden

P107: IL-34 and IL-36 family expressing cytotoxic T-cells and plasmacytoid dendritic cells are increased 
in patients with active inflammatory bowel diseaseECCO '16 Amsterdam
Year: 2016
Authors:

G. Fonseca Camarillo*1, E. Iturriaga Goyon2, J. Furuzawa Carballeda3, J. Yamamoto Furusho2

1Instituto Nacional de Ciencias Médicas y Nutrición, Inflammatory Bowel Disease Clinic, Department of Gastroenterology, Mexico, Mexico, 2Instituto Nacional de Ciencias Médicas y Nutrición, Inflammatory Bowel Disease Clinic. Department of Gastroenterology, Mexico, Mexico, 3Instituto Nacional de Ciencias Médicas y Nutrición, Department of Immunology and Rheumatology, Mexico, Mexico

P108: Cytokine levels differ during pregnancy amongst women with ulcerative colitis and Crohn’s diseaseECCO '16 Amsterdam
Year: 2016
Authors:

V. W. Huang*1, N. Hotte2, L. Ambrosio1, K. Smith2, J. Bal1, R. Foshaug1, K. I. Kroeker1, B. Halloran1, L. Dieleman1, R. N. Fedorak1, K. Madsen2

1University of Alberta, Gastroenterology, Edmonton, Canada, 2University of Alberta, Edmonton, Canada

P109: Effect of dysbiosis on the growth and colitis susceptibility in DSS colitis modelECCO '16 Amsterdam
Year: 2016
Authors:

C. S. Eun*, D. S. Han, A. R. Lee, Y. R. Lee

Hanyang University Guri Hospital, Gastroenterology, Guri, South Korea

P110: Cigarette smoke modulates the effect of dextran sulfate sodium–induced colitis on a subpopulation of T-cells in blood and colon in miceECCO '16 Amsterdam
Year: 2016
Authors:

J. Daniluk*1, U. Daniluk2, M. Rusak3, J. Reszec4, M. Dabrowska3, A. Dabrowski1

1Medical University of Bialystok, Department of Gastroenterology and Internal Medicine, Bialystok, Poland, 2Medical University of Bialystok, Department of Paediatrics, Gastroenterology and Allergology, Bialystok, Poland, 3Medical University of Bialystok, Department of Haematological Diagnostics, Bialystok, Poland, 4Medical University of Bialystok, Department of Medical Pathomorphology, Bialystok, Poland

P111: Differences in therapies and intestinal resection rates between adult and elderly onset Crohn’s diseaseECCO '16 Amsterdam
Year: 2016
Authors:

C. Alexakis*1, S. Saxena2, V. Chhaya1, E. Cecil2, R. Pollok1

1St George’s Hospital, Gastroenterology, London, United Kingdom, 2Department of Primary Care and Public Health, Imperial College, London, United Kingdom

P112: Validation of the simplified Geboes score for ulcerative colitisECCO '16 Amsterdam
Year: 2016
Authors:

A. Jauregui-Amezaga*1, Y. Das2, T. Lobatón3, B. Lemmens2, T. Bessissow4, M. Ferrante1, G. Van Assche1, R. Bisschops1, K. Geboes2, G. De Hertogh2, S. Vermeire1

1University Hospitals Leuven, Gastroenterology, Leuven, Belgium, 2University Hospitals Leuven, Pathology, Leuven, Belgium, 3Hospital Universitari Germans Trias i Pujol, Gastroenterology, Badalona, Spain, 4Mc Gill University Health Centre, Gastroenterology, Montreal, Canada

P113: Quality of life in paediatric Crohn’s disease: data from the Imagekids studyECCO '16 Amsterdam
Year: 2016
Authors:

V. M. Navas-López*1, 2, J. Martín-de-Carpi3, A. Grant4, T. D. Walters5, F. Ruemmele6, D. Mack7, M. Sladek8, R. Shamir9, R. Shaoul10, S. Saeed11, R. K. Russell12, R. Cytter-Kuint13, A. Griffiths14, D. Turner13, A. Otley4

1Paediatric Gastroenterology and Nutrition Unit, Hospital Materno Infantil, Málaga, Spain, 2IBIMA, Biomedical Institute of Málaga, Málaga, Spain, 3Unit for the Comprehensive Care of Paediatric Inflammatory Bowel Disease, Department of Paediatric Gastroenterology, Hepatology and Nutrition, Barcelona, Spain, 4IWK Health Centre, Halifax, Nova Scotia, Canada, 5Hospital for Sick Children, Toronto, Ontario, Canada, 6Hôpital Necker-Enfants Malades, Paris, France, 7Children’s Hospital of Eastern Ontario, Ottawa, Ontario, Canada, 8Jagiellonian University Medical College, Krakow, Poland, 9Schneider Children’s Medical Centre, Petach Tikvah, Israel, 10Rambam Health Care Campus, Haifa, Israel, 11Cincinnati Children’s Hospital Medical Centre, Cincinnati, Ohio,United States, 12Royal Hospital for Children, Glasgow, United Kingdom, 13Institute of Paediatric Gastroenterology, Shaare Zedek Medical Centre, The Hebrew University of Jerusalem, Jerusalem, Israel, 14Hospital for Sick Children, Toronto, Canada

P114: Predictors of clinical response during adalimumab therapy in Crohn’s disease patients: a German non-interventional studyECCO '16 Amsterdam
Year: 2016
Authors:

I. Blumenstein*1, R. Atreya2, G. Greger3, B. Bokemeyer4, P. Nurwakagari3, M. F. Neurath2, B. Wittig3

1Goethe-University Frankfurt, Gastroenterology, Frankfurt am Main, Germany, 2University Erlangen, Erlangen, Germany, 3AbbVie Deutschland GmbH & Co.KG, Wiesbaden, Germany, 4Gastroenterology Practice, Minden, Germany

P115: Standardising assessment and documentation of pouchoscopyECCO '16 Amsterdam
Year: 2016
Authors:

V. A. van der Ploeg1, Y. Maeda*1, O. D. Faiz1, A. L. Hart2, S. K. Clark1

1St Mark’s Hospital, Department of Surgery, Harrow, United Kingdom, 2St Mark’s Hospital, Department of Gastroenterology, Harrow, United Kingdom

P116: Usefulness of consecutive faecal calprotectin measurements to predict relapse in inflammatory bowel disease patients under maintenance treatment with anti-TNF therapy: a prospective longitudinal cohort studyECCO '16 Amsterdam
Year: 2016
Authors:

R. Ferreiro*, M. Barreiro-de Acosta, A. Lorenzo, J. E. Dominguez-Munoz

University Hospital Santiago de Compostela, Gastroenterology, Santiago, Spain

P117: Comparison between calprotectin and HMGB1 as faecal biomarkers of intestinal inflammation in paediatric and adult inflammatory bowel diseaseECCO '16 Amsterdam
Year: 2016
Authors:

F. Palone*1, R. Vitali1, L. Stronati2, R. D’Incà3, A. Armuzzi4, B. Barberio3, C. Felice4, D. Pugliese4, A. Dilillo5, M. Mennini5, S. Cucchiara5

1ENEA, Department of Radiobiology and Humal Health, Rome, Italy, 2Sapienza University of Rome, Department of Cellular Biotechnology and Haematology, Rome, Italy, 3University of Padova, Department of Surgical, Oncological and Gastroenterological Sciences, Padova, Italy, 4Internal Medicine and Gastroenterology - Complesso Integrato Columbus - Catholic University, Department of Internal Medicine, Rome, Italy, 5Sapienza, Rome, Paediatric Gastroenterology and Liver Unit, Rome, Italy

P118: Difference of health-related quality of life between East and South Asian incident inflammatory bowel disease patients and factors associated with improvement of HRQoL at follow-up: analysis of an Asia-Pacific population-based cohortECCO '16 Amsterdam
Year: 2016
Authors:

H. Chan*1, D. Ong2, Z. Zeng3, W. Tang1, J. Ching1, K. L. Goh4, I. Hilmi4, P. Pisespongsa5, S. Aniwan6, J. Limsrivilai7, J. De Silva8, M. Niriella8, Y. F. Wang9, O. Qin9, K. Wu10, M. Abdullah11, M. Simadibrata11, H. H. Yu12, K. K. Ng13, K. L. Ling14, M. H. Chen3, J. J. Sung1, S. Ng1

1Institute of Digestive Disease, the Chinese University of Hong Kong, Hong Kong, China, 2National University Hospital of Singapore, Singapore, 3The First Affiliated Hospital of San Yat Sen University, Guangzhou, China, 4University of Malaya Medical Centre, Kuala Lumpur, Malaysia, 5Maharaj Nakorn Chiangmai Hospital, Chiangmai, Thailand, 6King Chulalongkorn Memorial Hospital, Bangkok, Thailand, 7Siriraj Hosptial, Bangkok, Thailand, 8Colombo North Teaching Hospital, Ragama, Sri Lanka, 9West China Hospital, Sichuan University, Chengdu, China, 10Department of Gastroenterology, Xijing Hospital, Fourth Military Medical University, Shaanxi, China, 11Faculty of Medicine Universitas Indonesia/Dr Cipto Mangunkusumo Hospital, Depok Municipality, Indonesia, 12Kiangwu Hospital, Macau, Macao, 13Hospital Conde S Januario, Macau, Macao, 14Singapore General Hospital, Singapore, Singapore

P119: Diagnostic performance of different calprotectin assaysECCO '16 Amsterdam
Year: 2016
Authors:

A. A. Wulandari1, J. Schulz1, F. Hartmann2,3, A. Dignass2, 3, J. Stein*1,3

1DGD Clinics Sachsenhausen, Frankfurt/Main, Germany, 2Agaplesion Markus Krankenhaus, Frankfurt/Main, Germany, 3Interdisciplinary Crohn Colitis Centre Rhein-Main, Frankfurt/Main, Germany

P120: Faecal calprotectin and S100A12 detect the early response to treatment by quantifying colonic inflammation in patients with ulcerative colitisECCO '16 Amsterdam
Year: 2016
Authors:

T. Kobayashi*, T. Toyonaga, S. Kuronuma, O. Takeuchi, M. Nakano, E. Saito, S. Umeda, N. Watanabe, T. Hibi

Kitasato University Kitasato Institute Hospital, Centre for Advanced IBD Research and Treatment, Tokyo, Japan

P121: Patients’ point of view regarding acceptability and usefulness of inflammatory bowel diseases monitoring tools: results from a nationwide multicentre study (the ACCEPT study)ECCO '16 Amsterdam
Year: 2016
Authors:

A. Buisson*1, 2, F. Gonzalez3, F. Poullenot4, S. Nancey5, E. Sollellis1, M. Fumery6, B. Pariente7, M. Flamant8, A. Bourreille9, G. Bonnaud10, S. Mathieu11, A. Thevenin12, M. Duruy13, J. FILIPPI14, F. L’hopital15, F. Luneau16, V. Michalet15, J. Genès15, A. Achim17, E. Cruzille15, G. Bommelaer1, 2, D. Laharie18, L. Peyrin-Biroulet19, B. Pereira20, M. Nachury21, G. Bouguen22

1University Hospital Estaing, Gastroenterology Department, Clermont-Ferrand, France, 2UMR 1071 Inserm/Université d’Auvergne; USC-INRA 2018, Microbes, Intestine, Inflammation and Susceptibility of the Host, Clermont-Ferrand, France, 3Private practice, Nimes, France, 4University Hospital, Gastroenterology Department, Bordeaux, France, 5Hospices Civils de Lyon, Lyon-Sud Hospital, Gastroenterology, Pierre Benite, France, 6University Hospital, Gastroenterology Department, Amiens, France, 7University Hospital, Gastroenterology Department, Lille, France, 8Private practice, Nantes, France, 9University Hospital, Gastroenterology Department, Nantes, France, 10Private practice, Cornebarrieu, France, 11Private practice, Clermont-Ferrand, France, 12Private practice, St Quentin, France, 13Private practice, Arles, France, 14Archet 2 University Hospital, Department of Gastroenterology, Nice, France, 15Private practice, Riom, France, 16Private practice, Chateauroux, France, 17Private practice, Beaumont, France, 18University Hospital, Bordeaux, France, 19CHU Nancy Brabois, Department of Gastroenterology, Vandoeuvre les Nancy, France, 20GM – Clermont-Ferrand University and Medical Centre, Biostatistics Unit , Clermont-Ferrand, France, 21University Hospital of Lille, Gastroenterology, Lille, France, 22University Hospital, Rennes, France

P122: Role of diffusion-weighted imaging in MRI-enterography for the evaluation of surgical risk in patients with Crohn’s diseaseECCO '16 Amsterdam
Year: 2016
Authors:

A. Testa*1, A. Rispo1, P. Mainenti2, D. Musto1, N. Imperatore1, M. Rea1, O.M. Nardone1, M. L. Taranto1, F. Castiglione1

1University ‘Federico II’ of Naples, Department of Clinical Medicine and Surgery, Naples, Italy, 2University ‘Federico II’ of Naples, Naples, Italy

P123: Significance of serological markers in the disease course of ulcerative colitisECCO '16 Amsterdam
Year: 2016
Authors:

G. Kovacs*1, N. Sipeki1, K. Palatka1, I. Altorjay1, K. Fechner2, 
G. L. Norman3, Z. Shums3, G. Veres4, P. L. Lakatos5, M. Papp1

1University of Debrecen, Clinical Centre, Department of Internal Medicine, Division of Gastroenterology, Debrecen, Hungary, 2Institute of Experimental Immunology, Euroimmun AG, Lubeck, Germany, 3Inova Diagnostics, Inc., San Diego, California, United States, 4Semmelweis University, First Department of Paediatrics, Budapest, Hungary, 5Semmelweis University, First Department of Medicine, Budapest, Hungary

P124: Systematic review of the impact of psychological morbidity and associated risk factors in young people with inflammatory bowel diseaseECCO '16 Amsterdam
Year: 2016
Authors:

A. J. Brooks*1, G. Rowse2, A. Ryder2, E. J. Peach2, B. M. Corfe3, A. J. Lobo1

1Sheffield Teaching Hospitals NHS Foundation Trust, Academic Department of Gastroenterology, Sheffield, United Kingdom, 2University of Sheffield, Department of Psychology, Sheffield, United Kingdom, 3University of Sheffield, Department of Oncology, Sheffield, United Kingdom